Printer Friendly

NinePoint Medical elects Eman Namati, PhD as CEO.

M2 PHARMA-July 2, 2018-NinePoint Medical elects Eman Namati, PhD as CEO

(C)2018 M2 COMMUNICATIONS

Medical device company NinePoint Medical, Inc revealed on Sunday the addition of Eman Namati, PhD as its president and chief executive officer.

The company said Dr Namati succeeds Christopher von Jako, PhD, who will continue to serve on the board of directors as an independent member.

In the senior positions in the company, Dr Namati will assume day-to-day leadership, while working in collaboration with Merit Medical Systems Inc (NASDAQ:MMSI), who now manages the sales distribution and customer service for the NvisionVLE Imaging System, which provides a unique and clinically valuable new perspective on esophageal disease.

Prior to the promotion, Dr Namati was a technical co-founder as well as vice president of Research and Development at the company, which he joined in 2010.

Previously, Dr Namati was a researcher developing optical imaging systems at Massachusetts General Hospital.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jul 2, 2018
Words:163
Previous Article:AstraZeneca and Merck wins PMDA approval for LYNPARZA (olaparib) tablets for breast cancer treatment in Japan.
Next Article:Alteogen & Lynkogen partnership to develop proprietary fusion proteins for treating NASH and metabolic diseases.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters